APHY Financials 07/15/2014 19:29:17 Assured Pharm

APHY Financials 07/15/2014 19:29:17
Assured Pharmacy, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 5,193 5,636 16,445 16,277
Cost of Revenue 4,072 4,309 13,221 13,161
Gross Profit 1,120 1,327 3,224 3,116
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 4,020 4,174 5,991 5,122
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,900) (2,847) (2,767) (2,006)
Income From Continuing Operations
Add'l Income/Expense Items 1,737 267 426 (620)
Earnings Before Interest and Tax (1,162) (2,580) (2,341) (2,626)
Interest Expense 1,262 1,400 918 375
Earnings Before Tax (2,424) (3,979) (3,259) (3,001)
Income Tax 328 9 - -
Minority Interest - - 12 12
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,752) (3,989) (3,288) (3,013)
Non Recurring Events
Discontinued Operations (609) (17) - (5)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,362) (4,006) (3,271) (3,018)
Preferred Stock and Other Adjustments (2,193) - - (61)
Net Income Applicable to Common Shareholders (5,554) (4,006) (3,271) (3,078)